Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Panic Disorders Market Over the Coming Decade?

Over the past few years, there has been a consistent growth in the market size for panic disorders. It is projected that it will increase from $10.73 billion in 2024 to $11.19 billion in 2025, expanding at a compound annual growth rate (CAGR) of 4.3%. The growth during the historic period can be attributed to factors such as the use of antidepressant medications, heightened awareness of mental health, escalating stress levels, accessibility to mental health services, and improvements in diagnostic criteria.

The market for panic disorders is predicted to experience robust expansion in the coming years. The market is projected to reach $13.96 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.7%. Factors contributing to the growth during the predicted period include the advent of new pharmacological therapies, telepsychiatry services, attention towards comorbidities, international mental health campaigns, the incorporation of pharmacogenomics in treatments, and public awareness programs. Key trends expected to emerge during the forecast period are digital interventions in mental health, telemedicine for treating panic disorder, medicine innovations, research into neurobiology, and remote surveillance and wearable tech.

How Are the key drivers expanding the growth of the Panic Disorders Market?

The anticipated rise in psychiatric patients is predicted to fuel the expansion of the panic disorder market. People suffering from psychiatric disorders or mental illnesses, which interfere with thinking, emotion, and social behavior, often experience panic disorder. This disorder is characterized by bursts of intense, sudden fear. The usual treatment involves mixing various therapeutic methods, medication, and lifestyle modifications to ease panic attack symptoms, better the patient’s overall life quality, and assist them in effectively managing their condition. The State of Mental Health in America 2022 report disclosed that as of October 2022, the number of adults with any mental illness rose to 49,564,000, reflecting 19.86% of the total US population for that year. This is an increase from 19.00% (47,132,000 individuals) in 2021. Therefore, the rising number of psychiatric patients will stimulate the panic disorder market’s growth. Telehealth’s increasing use is also projected to boost the expansion of the panic disorders market. Telehealth, which uses electronic communication technologies such as secure videoconferencing, phone calls, and messages, supports remote delivery of health services and medical consultations. It offers psychotherapy and counseling support for individuals grappling with panic disorders. Therapists can conduct one-on-one or group therapy sessions via secure videoconferencing platforms. For instance, data from FAIR Health Inc. in April 2023 demonstrated a 7.3% national rise in telehealth usage, increasing from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. This growing use of telehealth is thus propelling the panic disorder market’s growth.

Get Your Free Sample of the Global Panic Disorders Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

What Are the Major Players Making an Impact in the Panic Disorders Market’s Growth?

Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc., Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd., VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.

Which Upcoming Trends Are Set to Influence the Panic Disorders Market’s Path Forward?

Leading firms in the panic disorder market are concentrating on creating advanced solutions like extended-release capsules to maintain their market standing. These capsules gradually release the active components over a predetermined span, usually 12 or 24 hours, providing treatment to conditions that necessitate prolonged medication intake. As an example, Granules India Ltd., an Indian pharmaceutical organization, obtained an abbreviated new drug application (ANDA) authorization from the US Food & Drug Administration (USFDA) for Venlafaxine hydrochloride extended-release capsules in May 2023. This proves bioequivalence with the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, produced by Upjohn US 2 LLC. The Venlafaxine HCl extended-release capsules are designed to manage conditions such as generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They function by enhancing the serotonin and norepinephrine levels in the brain, initiating the dosage generally at 75 mg per day and could be elevated as per the doctor’s discretion.

Get Instant Access to the Global Panic Disorders Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

What Are the Major Categories and Their Growth Dynamics in the Panic Disorders Market?

The panic disorders market covered in this report is segmented –

1) By Type: Agoraphobia, Social Anxiety Disorder (SAD), Obsessive-Compulsive Disorder (OCD), Bipolar Disorder, Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder

2) By Treatment: Medication, Beta Blockers, Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs), Benzodiazepines, Anti-Epilepsy, Other Treatments

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

4) By End Use: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacy Stores

Subsegments:

1) By Agoraphobia: Situational Agoraphobia, Non-Situational Agoraphobia

2) By Social Anxiety Disorder (SAD): Performance Anxiety, Generalized Social Anxiety

3) By Obsessive-Compulsive Disorder (OCD): Contamination OCD, Harm OCD, Checking OCD, Symmetry OCD

4) By Bipolar Disorder: Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder

5) By Post-Traumatic Stress Disorder (PTSD): Acute PTSD, Chronic PTSD, Complex PTSD

6) By Major Depressive Disorder: Recurrent Major Depressive Disorder, Single Episode Major Depressive Disorder

What Regions Are Steering Growth in the Panic Disorders Sector?

North America was the largest region in the panic disorders market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Can We Define the Panic Disorders Market and Its Key Components?

Panic disorder is a specific type of anxiety illness characterized by unanticipated and recurrent attacks of high anxiety accompanied by physical symptoms such as shortness of breath, chest pain, heart palpitations, nausea, and abdominal discomfort. Panic disorder is generally treated with medication and psychotherapy.

Browse Through More Similar Reports By The Business Research Company:

Basal Cell Carcinoma Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/basal-cell-carcinoma-treatment-global-market-report

Epidural Abscess Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/epidural-abscess-treatment-global-market-report

Crohn’s Disease (CD) Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: